Analysts Set Expectations for KYMR Q2 Earnings
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Stock analysts at Brookline Capital Management issued their Q2 2025 earnings per share estimates for Kymera Therapeutics in a research note issued on Thursday, February 27th. Brookline Capital Management analyst L. Cann expects that the company will post earnings of ($0.97) per share for the quarter. The […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Stock analysts at Brookline Capital Management issued their Q2 2025 earnings per share estimates for Kymera Therapeutics in a research note issued on Thursday, February 27th. Brookline Capital Management analyst L. Cann expects that the company will post earnings of ($0.97) per share for the quarter. The […]
